Global Parkinson’s Disease Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The Global Parkinson’s Disease Therapeutics Market Size was estimated at USD 2496.35 million in 2023 and is projected to reach USD 3541.12 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Parkinson’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson’s Disease Therapeutics market in any manner.
Global Parkinson’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Market Segmentation (by Type)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The Global Parkinson’s Disease Therapeutics Market Size was estimated at USD 2496.35 million in 2023 and is projected to reach USD 3541.12 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Parkinson’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson’s Disease Therapeutics market in any manner.
Global Parkinson’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Market Segmentation (by Type)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson’s Disease Therapeutics Market
- Overview of the regional outlook of the Parkinson’s Disease Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson’s Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbvie
9.1.1 Abbvie Parkinson’s Disease Therapeutics Basic Information
9.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
9.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
9.1.4 Abbvie Business Overview
9.1.5 Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
9.1.6 Abbvie Recent Developments
9.2 Biogen
9.2.1 Biogen Parkinson’s Disease Therapeutics Basic Information
9.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
9.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Parkinson’s Disease Therapeutics SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Boehringer Ingelheim GmbH
9.3.1 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
9.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
9.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
9.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
9.3.5 Boehringer Ingelheim GmbH Business Overview
9.3.6 Boehringer Ingelheim GmbH Recent Developments
9.4 F. Hoffman-La Roche
9.4.1 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
9.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
9.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
9.4.4 F. Hoffman-La Roche Business Overview
9.4.5 F. Hoffman-La Roche Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
9.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
9.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 H. Lundbeck A/S
9.6.1 H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
9.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
9.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
9.6.4 H. Lundbeck A/S Business Overview
9.6.5 H. Lundbeck A/S Recent Developments
9.7 Impax Labs
9.7.1 Impax Labs Parkinson’s Disease Therapeutics Basic Information
9.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
9.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
9.7.4 Impax Labs Business Overview
9.7.5 Impax Labs Recent Developments
9.8 Newron Pharmaceuticals SpA
9.8.1 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
9.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
9.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
9.8.4 Newron Pharmaceuticals SpA Business Overview
9.8.5 Newron Pharmaceuticals SpA Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Parkinson’s Disease Therapeutics Basic Information
9.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
9.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
9.9.4 Novartis AG Business Overview
9.9.5 Novartis AG Recent Developments
9.10 Orion Corporation
9.10.1 Orion Corporation Parkinson’s Disease Therapeutics Basic Information
9.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
9.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
9.10.4 Orion Corporation Business Overview
9.10.5 Orion Corporation Recent Developments
9.11 Teva Pharmaceutical Industries Ltd.
9.11.1 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
9.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
9.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
9.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.12 UCB S.A.
9.12.1 UCB S.A. Parkinson’s Disease Therapeutics Basic Information
9.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
9.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
9.12.4 UCB S.A. Business Overview
9.12.5 UCB S.A. Recent Developments
9.13 Livzon Pharmaceutical
9.13.1 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.13.4 Livzon Pharmaceutical Business Overview
9.13.5 Livzon Pharmaceutical Recent Developments
9.14 Haisco Pharmaceutical
9.14.1 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.14.4 Haisco Pharmaceutical Business Overview
9.14.5 Haisco Pharmaceutical Recent Developments
9.15 Jingxin Pharmaceutical
9.15.1 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.15.4 Jingxin Pharmaceutical Business Overview
9.15.5 Jingxin Pharmaceutical Recent Developments
9.16 Dongcheng Biochemicals
9.16.1 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
9.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
9.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
9.16.4 Dongcheng Biochemicals Business Overview
9.16.5 Dongcheng Biochemicals Recent Developments
10 PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Parkinson’s Disease Therapeutics Market Size Forecast
10.2 Global Parkinson’s Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson’s Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson’s Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson’s Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson’s Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson’s Disease Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinson’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson’s Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbvie
9.1.1 Abbvie Parkinson’s Disease Therapeutics Basic Information
9.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
9.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
9.1.4 Abbvie Business Overview
9.1.5 Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
9.1.6 Abbvie Recent Developments
9.2 Biogen
9.2.1 Biogen Parkinson’s Disease Therapeutics Basic Information
9.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
9.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Parkinson’s Disease Therapeutics SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Boehringer Ingelheim GmbH
9.3.1 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
9.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
9.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
9.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
9.3.5 Boehringer Ingelheim GmbH Business Overview
9.3.6 Boehringer Ingelheim GmbH Recent Developments
9.4 F. Hoffman-La Roche
9.4.1 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
9.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
9.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
9.4.4 F. Hoffman-La Roche Business Overview
9.4.5 F. Hoffman-La Roche Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
9.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
9.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 H. Lundbeck A/S
9.6.1 H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
9.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
9.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
9.6.4 H. Lundbeck A/S Business Overview
9.6.5 H. Lundbeck A/S Recent Developments
9.7 Impax Labs
9.7.1 Impax Labs Parkinson’s Disease Therapeutics Basic Information
9.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
9.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
9.7.4 Impax Labs Business Overview
9.7.5 Impax Labs Recent Developments
9.8 Newron Pharmaceuticals SpA
9.8.1 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
9.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
9.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
9.8.4 Newron Pharmaceuticals SpA Business Overview
9.8.5 Newron Pharmaceuticals SpA Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Parkinson’s Disease Therapeutics Basic Information
9.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
9.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
9.9.4 Novartis AG Business Overview
9.9.5 Novartis AG Recent Developments
9.10 Orion Corporation
9.10.1 Orion Corporation Parkinson’s Disease Therapeutics Basic Information
9.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
9.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
9.10.4 Orion Corporation Business Overview
9.10.5 Orion Corporation Recent Developments
9.11 Teva Pharmaceutical Industries Ltd.
9.11.1 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
9.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
9.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
9.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.12 UCB S.A.
9.12.1 UCB S.A. Parkinson’s Disease Therapeutics Basic Information
9.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
9.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
9.12.4 UCB S.A. Business Overview
9.12.5 UCB S.A. Recent Developments
9.13 Livzon Pharmaceutical
9.13.1 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.13.4 Livzon Pharmaceutical Business Overview
9.13.5 Livzon Pharmaceutical Recent Developments
9.14 Haisco Pharmaceutical
9.14.1 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.14.4 Haisco Pharmaceutical Business Overview
9.14.5 Haisco Pharmaceutical Recent Developments
9.15 Jingxin Pharmaceutical
9.15.1 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
9.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
9.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
9.15.4 Jingxin Pharmaceutical Business Overview
9.15.5 Jingxin Pharmaceutical Recent Developments
9.16 Dongcheng Biochemicals
9.16.1 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
9.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
9.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
9.16.4 Dongcheng Biochemicals Business Overview
9.16.5 Dongcheng Biochemicals Recent Developments
10 PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Parkinson’s Disease Therapeutics Market Size Forecast
10.2 Global Parkinson’s Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson’s Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson’s Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson’s Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson’s Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson’s Disease Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinson’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson’s Disease Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 13. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Global Parkinson’s Disease Therapeutics Sales by Type (Kilotons)
Table 23. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson’s Disease Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Application
Table 30. Global Parkinson’s Disease Therapeutics Market Size by Application
Table 31. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbvie Parkinson’s Disease Therapeutics Basic Information
Table 44. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 45. Abbvie Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbvie Business Overview
Table 47. Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
Table 48. Abbvie Recent Developments
Table 49. Biogen Parkinson’s Disease Therapeutics Basic Information
Table 50. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 51. Biogen Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Parkinson’s Disease Therapeutics SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
Table 56. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 57. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
Table 59. Boehringer Ingelheim GmbH Business Overview
Table 60. Boehringer Ingelheim GmbH Recent Developments
Table 61. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
Table 62. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 63. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. F. Hoffman-La Roche Business Overview
Table 65. F. Hoffman-La Roche Recent Developments
Table 66. GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
Table 67. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 68. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
Table 72. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 73. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. H. Lundbeck A/S Business Overview
Table 75. H. Lundbeck A/S Recent Developments
Table 76. Impax Labs Parkinson’s Disease Therapeutics Basic Information
Table 77. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 78. Impax Labs Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Impax Labs Business Overview
Table 80. Impax Labs Recent Developments
Table 81. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
Table 82. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 83. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Newron Pharmaceuticals SpA Business Overview
Table 85. Newron Pharmaceuticals SpA Recent Developments
Table 86. Novartis AG Parkinson’s Disease Therapeutics Basic Information
Table 87. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 88. Novartis AG Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Recent Developments
Table 91. Orion Corporation Parkinson’s Disease Therapeutics Basic Information
Table 92. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 93. Orion Corporation Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Orion Corporation Business Overview
Table 95. Orion Corporation Recent Developments
Table 96. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
Table 97. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 98. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Teva Pharmaceutical Industries Ltd. Business Overview
Table 100. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 101. UCB S.A. Parkinson’s Disease Therapeutics Basic Information
Table 102. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 103. UCB S.A. Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. UCB S.A. Business Overview
Table 105. UCB S.A. Recent Developments
Table 106. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 107. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 108. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Livzon Pharmaceutical Business Overview
Table 110. Livzon Pharmaceutical Recent Developments
Table 111. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 112. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 113. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Haisco Pharmaceutical Business Overview
Table 115. Haisco Pharmaceutical Recent Developments
Table 116. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 117. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 118. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jingxin Pharmaceutical Business Overview
Table 120. Jingxin Pharmaceutical Recent Developments
Table 121. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
Table 122. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 123. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Dongcheng Biochemicals Business Overview
Table 125. Dongcheng Biochemicals Recent Developments
Table 126. Global Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Parkinson’s Disease Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Parkinson’s Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Parkinson’s Disease Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson’s Disease Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 13. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Global Parkinson’s Disease Therapeutics Sales by Type (Kilotons)
Table 23. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson’s Disease Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinson’s Disease Therapeutics Sales (Kilotons) by Application
Table 30. Global Parkinson’s Disease Therapeutics Market Size by Application
Table 31. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbvie Parkinson’s Disease Therapeutics Basic Information
Table 44. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 45. Abbvie Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbvie Business Overview
Table 47. Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
Table 48. Abbvie Recent Developments
Table 49. Biogen Parkinson’s Disease Therapeutics Basic Information
Table 50. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 51. Biogen Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Parkinson’s Disease Therapeutics SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
Table 56. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 57. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
Table 59. Boehringer Ingelheim GmbH Business Overview
Table 60. Boehringer Ingelheim GmbH Recent Developments
Table 61. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
Table 62. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 63. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. F. Hoffman-La Roche Business Overview
Table 65. F. Hoffman-La Roche Recent Developments
Table 66. GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
Table 67. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 68. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
Table 72. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 73. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. H. Lundbeck A/S Business Overview
Table 75. H. Lundbeck A/S Recent Developments
Table 76. Impax Labs Parkinson’s Disease Therapeutics Basic Information
Table 77. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 78. Impax Labs Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Impax Labs Business Overview
Table 80. Impax Labs Recent Developments
Table 81. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
Table 82. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 83. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Newron Pharmaceuticals SpA Business Overview
Table 85. Newron Pharmaceuticals SpA Recent Developments
Table 86. Novartis AG Parkinson’s Disease Therapeutics Basic Information
Table 87. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 88. Novartis AG Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Recent Developments
Table 91. Orion Corporation Parkinson’s Disease Therapeutics Basic Information
Table 92. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 93. Orion Corporation Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Orion Corporation Business Overview
Table 95. Orion Corporation Recent Developments
Table 96. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
Table 97. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 98. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Teva Pharmaceutical Industries Ltd. Business Overview
Table 100. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 101. UCB S.A. Parkinson’s Disease Therapeutics Basic Information
Table 102. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 103. UCB S.A. Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. UCB S.A. Business Overview
Table 105. UCB S.A. Recent Developments
Table 106. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 107. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 108. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Livzon Pharmaceutical Business Overview
Table 110. Livzon Pharmaceutical Recent Developments
Table 111. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 112. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 113. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Haisco Pharmaceutical Business Overview
Table 115. Haisco Pharmaceutical Recent Developments
Table 116. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 117. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 118. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jingxin Pharmaceutical Business Overview
Table 120. Jingxin Pharmaceutical Recent Developments
Table 121. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
Table 122. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 123. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Dongcheng Biochemicals Business Overview
Table 125. Dongcheng Biochemicals Recent Developments
Table 126. Global Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Parkinson’s Disease Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Parkinson’s Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Parkinson’s Disease Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson’s Disease Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinson’s Disease Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinson’s Disease Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinson’s Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson’s Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson’s Disease Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinson’s Disease Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinson’s Disease Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinson’s Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson’s Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
